Abstract
The recent COVID-19 pandemic caused by the SARS-CoV-2 virus has conditioned a severe pulmonary disease with multi-system involvement. Recently, a variety of neurological disorders has been associated with this infection, including lack of smell (anosmia), lack of taste (ageusia), headache, myalgias, confusional states (encephalopathies), dizziness, seizures, strokes, and cranial and peripheral nerve palsies. A direct damage by the virus as well as secondary inflammatory and immune mechanisms triggered by the viral infection may be responsible for the nervous system abnormalities. The virus can gain access to the nervous system from the bloodstream and/or through the peripheral nerves in a retrograde transport. There is no specific therapy for these problems, thus treatment is symptomatic and supportive. Oftentimes a prothrombotic state is created during the infection; hence, anticoagulation should be considered in those patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.